Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E0JF
|
|||
Former ID |
DIB001218
|
|||
Drug Name |
Pirazolac
|
|||
Synonyms |
MY-309; ZK-76604
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Discontinued in Preregistration | [1] | |
Company |
Bayer Schering Pharma AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H12ClFN2O2
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=CN(N=C2CC(=O)O)C3=CC=C(C=C3)F)Cl
|
|||
InChI |
1S/C17H12ClFN2O2/c18-12-3-1-11(2-4-12)15-10-21(20-16(15)9-17(22)23)14-7-5-13(19)6-8-14/h1-8,10H,9H2,(H,22,23)
|
|||
InChIKey |
YAMFWQIVVMITPG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 71002-09-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin G/H synthase (COX) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000980) | |||
REF 2 | Differential dosing study of pirazolac, a new non-steroidal anti-inflammatory agent, in patients with rheumatoid arthritis. Curr Med Res Opin. 1985;9(8):542-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.